Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility.
Publication
, Journal Article
Vickers, AJ; Pencina, MJ
Published in: Eur Urol
September 2013
Duke Scholars
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
September 2013
Volume
64
Issue
3
Start / End Page
394 / 396
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Male
- Kallikreins
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vickers, A. J., & Pencina, M. J. (2013). Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol, 64(3), 394–396. https://doi.org/10.1016/j.eururo.2013.03.003
Vickers, Andrew J., and Michael J. Pencina. “Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility.” Eur Urol 64, no. 3 (September 2013): 394–96. https://doi.org/10.1016/j.eururo.2013.03.003.
Vickers AJ, Pencina MJ. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol. 2013 Sep;64(3):394–6.
Vickers, Andrew J., and Michael J. Pencina. “Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility.” Eur Urol, vol. 64, no. 3, Sept. 2013, pp. 394–96. Pubmed, doi:10.1016/j.eururo.2013.03.003.
Vickers AJ, Pencina MJ. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol. 2013 Sep;64(3):394–396.
Published In
Eur Urol
DOI
EISSN
1873-7560
Publication Date
September 2013
Volume
64
Issue
3
Start / End Page
394 / 396
Location
Switzerland
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Male
- Kallikreins
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences